7-21744562-A-G
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1
The NM_001277115.2(DNAH11):c.8279A>G(p.Gln2760Arg) variant causes a missense change. The variant allele was found at a frequency of 0.000173 in 1,613,618 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001277115.2 missense
Scores
Clinical Significance
Conservation
Publications
- primary ciliary dyskinesia 7Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), ClinGen
- primary ciliary dyskinesiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| DNAH11 | NM_001277115.2 | c.8279A>G | p.Gln2760Arg | missense_variant | Exon 50 of 82 | ENST00000409508.8 | NP_001264044.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00101 AC: 154AN: 152240Hom.: 1 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.000294 AC: 73AN: 248510 AF XY: 0.000245 show subpopulations
GnomAD4 exome AF: 0.0000855 AC: 125AN: 1461260Hom.: 0 Cov.: 31 AF XY: 0.0000812 AC XY: 59AN XY: 726838 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00101 AC: 154AN: 152358Hom.: 1 Cov.: 33 AF XY: 0.00109 AC XY: 81AN XY: 74508 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:2
- -
In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
Primary ciliary dyskinesia Benign:2
- -
This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at